Rock Springs Capital Management LP 13D and 13G filings for Spruce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:11 pm Purchase |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 2,609,125 6.410% |
986,436 (+60.79%) |
Filing |
| 2023-02-14 2:56 pm Unchanged |
2022-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,622,689 6.890% |
0 (Unchanged) |
Filing |
| 2022-02-14 6:24 pm Sale |
2021-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,622,689 6.920% |
-8,311 (-0.51%) |
Filing |
| 2021-02-16 4:32 pm Sale |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,631,000 7.030% |
-77,673 (-4.55%) |
Filing |
| 2020-10-19 4:14 pm Purchase |
2020-10-09 | 13G | Spruce Biosciences, Inc. SPRB |
Rock Springs Capital Management LP | 1,708,673 7.380% |
1,708,673 (New Position) |
Filing |